ABSTRACT

The increasingly international nature of the pharmaceutical and chemical industry has

resulted in many common regulatory goals in the major national regulatory agencies

and development of multinational organizations, such as the Organization for Economic

Co-operation and Development (OECD) and the International Conference on

Harmonization (ICH), to reduce inconsistencies in regulatory burdens and reduce the

number of animals used unnecessarily in regulatory testing.